Arformoterol Tartrate Inhalation Solution

Ritedose Pharmaceuticals, LLC🇺🇸 United States

FDA Page

Effective Date: Dec 20, 2023
Approval ID: ef524b4c-68d7-c464-e053-2a95a90a7f96
Products: 1 registered
Version: 2

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

Arformoterol Tartrate Inhalation Solution, 15 mcg/2 mL These highlights do not include all the information needed to use ARFORMOTEROL TARTRATE INHALATION SOLUTION safely and effectively. See full prescribing information for ARFORMOTEROL TARTRATE INHALATION SOLUTION ARFORMOTEROL TARTRATE INHALATION SOLUTION Initial U.S. Approval: 2006

Quick Stats

Total Products1

Labelers2

Label Sections19

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.